title: Incremental peritoneal dialysis: Clinical outcomes and residual kidney function preservation.
abstract: BACKGROUND
  Initiation of peritoneal dialysis (PD) with 3 exchanges has become common practice in recent years, despite the lack of published clinical data.
  
  
  OBJECTIVE
  To describe experience with incremental peritoneal dialysis (IPD) at a single site.
  
  
  METHODS
  A total of 46 IPD patients undergoing 2-year clinical, laboratory, treatment and progression follow-up.
  
  
  RESULTS
  To 25% of patients were trasplanted on IPD. Mean time on IPD before transfer to conventional PD of 24 months, half of the patients because of fluid balance. Good clinical and biochemical results with a peritonitis rate of one episode per 99 months. There was an improvement in the loss of residual kidney function compared to the pre-dialysis period (-7.06 vs. -1.58ml/min/year; P=.0001).
  
  
  CONCLUSIONS
  IPD with 3 peritoneal exchanges offers good results. Most patients remain stable during the first 2 years and there is an improvement in the loss of residual kidney function compared to the pre-dialysis period.
authors.affiliation: Servicio de Nefrología, Hospital Universitari Arnau de Vilanova, Lérida, España. Electronic address: mborras56@gmail.com.
authors.forename: Mercè
authors.initials: M
authors.lastname: Borràs Sans
authors.affiliation: Servicio de Nefrología, Hospital Universitari Arnau de Vilanova, Lérida, España.
authors.forename: Andrea
authors.initials: A
authors.lastname: Chacón Camacho
authors.affiliation: Servicio de Nefrología, Hospital Universitari Arnau de Vilanova, Lérida, España.
authors.forename: Carla
authors.initials: C
authors.lastname: Cerdá Vilaplana
authors.affiliation: Servicio de Nefrología, Hospital Universitari Arnau de Vilanova, Lérida, España.
authors.forename: Ana
authors.initials: A
authors.lastname: Usón Nuño
authors.affiliation: Servicio de Nefrología, Hospital Universitari Arnau de Vilanova, Lérida, España.
authors.forename: Elvira
authors.initials: E
authors.lastname: Fernández
mesh_terms: D000328:Adult; D000368:Aged; D000740:Anemia / Q000188:drug therapy / Q000209:etiology; D000068256:Darbepoetin alfa / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D005919:Glomerular Filtration Rate; D006801:Humans; D007668:Kidney / Q000503:physiopathology*; D007676:Kidney Failure, Chronic / Q000503:physiopathology / Q000601:surgery / Q000628:therapy*; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D010530:Peritoneal Dialysis / Q000009:adverse effects / Q000379:methods*; D010538:Peritonitis / Q000453:epidemiology; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D000068256:Darbepoetin alfa
keywords: Diálisis peritoneal incremental; Función renal residual; Incremental peritoneal dialysis; Inicio de diálisis; Initiation of dialysis; Residual kidney function